These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19378336)

  • 1. Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
    Ichimi T; Enokida H; Okuno Y; Kunimoto R; Chiyomaru T; Kawamoto K; Kawahara K; Toki K; Kawakami K; Nishiyama K; Tsujimoto G; Nakagawa M; Seki N
    Int J Cancer; 2009 Jul; 125(2):345-52. PubMed ID: 19378336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
    Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
    Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
    Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
    Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
    Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a microRNA expression vector for function analysis of microRNA.
    Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
    J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
    Matsushita R; Seki N; Chiyomaru T; Inoguchi S; Ishihara T; Goto Y; Nishikawa R; Mataki H; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Br J Cancer; 2015 Jul; 113(2):282-9. PubMed ID: 26057453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
    Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
    Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M
    Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of novel microRNA candidates from deep sequencing.
    Wu Q; Wang C; Guo L; Ge Q; Lu Z
    Clin Chim Acta; 2013 Jan; 415():239-44. PubMed ID: 23153516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.